NAVIGATOR shows valsartan delayed progression to type 2 diabete
Pfizer Discontinues A Phase 3 Study Of Figitumumab
Novel Drug for Chronic Management of Hyperuricemia in Gout Patients
Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 Diabetics
FDA Announces New Boxed Warning on Plavix
BioSante Announces Positive Leukemia Vaccine Results
FDA Approves Exaglo (hydromorphone HCl) Extended-Release Tablets
Forest, Almirall announce positive results from the ACCORD COPD I phase III study of aclidinium bromide
Pfizer, Debiopharm enter pact to co-develop investigational compound tremelimumab in advanced melanoma